Understanding the patient voice in gout: a quantitative study conducted in Europe
Open Access
- 18 February 2020
- journal article
- Published by Royal College of General Practitioners in BJGP Open
Abstract
BackgroundAlthough commonly diagnosed, gout often remains a poorly managed disease. This is partially due to a lack of awareness of the long-term effect of gout among patients and healthcare professionals.AimTo understand unmet needs for patients and provide insight into achieving better treatment.Design & settingA quantitative online questionnaire collected from 1100 people with gout from 14 countries within Europe.MethodPatients were recruited to complete an online survey via healthcare professional (HCP) referral, patient associations, or market research panels. Patients were included if they had been diagnosed with gout by a physician. Prior to commencement, patients were made aware that this study was sponsored by Grünenthal. The responses collected were collated and analyses were performed.ResultsPatients had an average of 2.9 gout flares within a 12-month period. Although 79% of patients were satisfied with treatment, inadequate gout control was also reported by 71% of patients. Furthermore, 84% experienced moderate-to-severe pain with their most recent flare. Of those who acknowledged treatment dissatisfaction, only 24% discussed other options with their GP. Most patients reported irregular follow-up and serum uric acid (sUA) monitoring. In addition, loss of belief that more can be done was a key barrier for patients.ConclusionPatients reported severe pain and social burden, coupled with low treatment expectation and lack of awareness of target sUA. Education around knowing and reaching sUA target is needed so that patients can receive and GPs can deliver higher quality management.Keywords
This publication has 19 references indexed in Scilit:
- Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohortsBMJ, 2018
- The Cost-effectiveness of Biannual Serum Urate (SU) Monitoring after Reaching Target in Gout: A Health Economic Analysis Comparing SU MonitoringThe Journal of Rheumatology, 2018
- Treat to target in goutRheumatology, 2017
- The British Society for Rheumatology Guideline for the Management of GoutRheumatology, 2017
- Treatment approaches and adherence to urate-lowering therapy for patients with goutPatient Preference and Adherence, 2017
- Treat-to-target (T2T) recommendations for goutAnnals Of The Rheumatic Diseases, 2016
- 2016 updated EULAR evidence-based recommendations for the management of goutAnnals Of The Rheumatic Diseases, 2016
- Global epidemiology of gout: prevalence, incidence and risk factorsNature Reviews Rheumatology, 2015
- Rising burden of gout in the UK but continuing suboptimal management: a nationwide population studyAnnals Of The Rheumatic Diseases, 2014
- Gout disease-specific quality of life and the association with gout characteristicsPatient Related Outcome Measures, 2010